Skip to content
buyWeak

Jon Christian Bates bought $82k of NUTX

Chief Financial Officer at Nutex Health, Inc.. 1,000 shares at an average of $81.81, traded Apr 8, 2025, filed Apr 14, 2025.

Conviction score
37
Value
$82k
1,000 shares
Holdings after
4,888
+26% from before
From 52-week low
+359%
low $18.50, close $84.94
From 52-week high
0%
high $84.94, as of Apr 8, 2025

Score components

  • Role
    CFO
    +22
  • Trade size
    $82k at market
    +9
  • Relative to holdings
    Holdings up 26%
    +6
  • Price context
    Mid range
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +22.5%, 3m -10.5%, 6m -21.2%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NUTXOct 9, 2026 · close 206.29
Since filing Apr 14, 2025: +59.1%SPY +46.7% · excess +12.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001486189-25-000017, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 1, 2025MOption exercise
Common Stock
+111$0.00$02,388Apr 14, 2025
Mar 1, 2025MOption exercise
Common Stock
+1,500$0.00$03,888Apr 14, 2025
Apr 8, 2025POpen-market purchase
Common Stock
+1,000$81.81$82k4,888Apr 14, 2025
Mar 10, 2025MOption exercise
Restricted Stock Unitsderivative
+3,500$0.00$06,500Apr 14, 2025

Related signals

Other insiders at Nutex Health, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
NUTXsell
Nutex Health, Inc.
Scott J Saunders
director
$43k
203 shares
-34%
43Moderate
NUTXbuy 4
Nutex Health, Inc.
Warren Hosseinion
President
$24k
252 shares
+3%
46Moderate
NUTXbuy 4
Nutex Health, Inc.
Frank E Jaumot
director
$14k
150 shares
-
33Weak
NUTXbuy 4
Nutex Health, Inc.
Kelvin Spears
director
$945
10 shares
+0%
38Weak
NUTXbuy 4
Nutex Health, Inc.
Pamela W. Montgomery
Chief Legal Officer-Healthcare
$7,021
79 shares
+3%
43Moderate
NUTXbuy
Nutex Health, Inc.
Jon Christian Bates
Chief Financial Officer
$103k
750 shares
+15%
46Moderate
NUTXbuy 2
Nutex Health, Inc.
Thomas T. Vo
Chief Executive Officer
$114k
500,000 shares
+0%
50Moderate
NUTXbuy 2
Nutex Health, Inc.
Joshua DeTillio
Chief Operating Officer
$34k
140,000 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jon Christian Bates bought $82k of NUTX | InsiderTell